Cart
sales@molnova.com
Home - Products - Others - Other Targets - ELOVL1-IN-2

ELOVL1-IN-2

CAS No. 2761063-79-8

ELOVL1-IN-2( —— )

Catalog No. M35448 CAS No. 2761063-79-8

ELOVL1-IN-2, a compound known as an inhibitor of the elongation of very long chain fatty acid 1 (ELOVL1) enzyme, exhibits a weak inhibitory effect on ELOVL1 (with an IC50 of 21 μM) and demonstrates moderate potency in a primary cellular assay conducted on HEK293 C26 cells (with an IC50 of 6.7 μM) .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 31 In Stock
10MG 55 In Stock
25MG 112 In Stock
50MG 207 In Stock
100MG 310 In Stock
200MG 445 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    ELOVL1-IN-2
  • Note
    Research use only, not for human use.
  • Brief Description
    ELOVL1-IN-2, a compound known as an inhibitor of the elongation of very long chain fatty acid 1 (ELOVL1) enzyme, exhibits a weak inhibitory effect on ELOVL1 (with an IC50 of 21 μM) and demonstrates moderate potency in a primary cellular assay conducted on HEK293 C26 cells (with an IC50 of 6.7 μM) .
  • Description
    ELOVL1-IN-2 is an elongation of very long chain fatty acid 1 (ELOVL1) enzyme inhibitor, ELOVL1-IN-2 shows weak ELOVL1 inhibition (IC50=21 μM) and moderate potency in a primary cellular assay (HEK293 C26 IC50=6.7 μM) .
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2761063-79-8
  • Formula Weight
    294.32
  • Molecular Formula
    C18H15FN2O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 6.67 mg/mL (22.66 mM; Ultrasonic; (HCL ，pH≈3)
  • SMILES
    O(CCC1=CC=C(F)C=C1)C=2C=CC(=CN2)C=3C=CC=NC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Boyd MJ, Collier PN, Clark MP, et al. Discovery of Novel, Orally Bioavailable Pyrimidine Ether-Based Inhibitors of ELOVL1. J Med Chem. 2021;64(24):17777-17794. ?
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Nyasol

    Nyasol may have potential to be developed as medicines for the treatment of allergies by inhibiting the activation of mast cells.

  • Sibiricaxanthone?A

    Sibiricaxanthone?A is a natural product from Polygala tenuifolia.

  • Baicalein 6-O-glucos...

    Baicalein 6-O-glucoside is a glucuronidation metabolite of Baicalein.

Sign In Join Free